Myriad Genetics
$17.39
24H
Market Cap
Volume
Supply
Price Chart
About Myriad Genetics - MYGN
Myriad Genetics, Inc. is a molecular diagnostic company that focuses on the development and marketing of predictive, personalized, and prognostic medicine tests for the assessment of various diseases, including a variety of cancers and other conditions. Some of their products provide genetic screening for cancer risks, like their BRACAnalysis test, which assesses a person's risk of developing breast and ovarian cancer based on detection of mutations in the BRCA1 and BRCA2 genes.
What are Myriad Genetics's core values and mission statement?
Myriad Genetics, Inc. is dedicated to making a difference in patients' lives through the discovery and commercialization of transformative molecular diagnostic tests that help to assess an individual's risk of developing disease, guide treatment decisions and assess the risk of disease progression and recurrence. Their core values emphasize patient care, innovation, commitment to quality, and collaboration to advance the field of personalized medicine.
Who founded Myriad Genetics and when?
Myriad Genetics, Inc. was founded in 1991 by Walter Gilbert, Mark Skolnick, and Peter Meldrum.
Who leads Myriad Genetics?
Leadership at Myriad Genetics can change over time, so the current leader as of the latest update could be different. It is best to refer to the company's official website or the latest press releases for the most current information on their executive team.
Where is Myriad Genetics located, and what is its base country?
Myriad Genetics, Inc. is headquartered in Salt Lake City, Utah, and its base country is the United States of America.
On which exchanges is Myriad Genetics traded?
Myriad Genetics, Inc. is traded on the NASDAQ under the ticker symbol MYGN.
Historical data
Myriad Genetics (MYGN) Price Live Data
The live price of Myriad Genetics (MYGN) is $17.39, with a trading volume of 822,368 in the last 24 hours. Wrapstocks updates the MYGN price in real-time. Myriad Genetics is down -1.58% in the last 24 hours. The company has a live market cap of $1,579,366,656.00 and a supply of 90,820,394 MYGN stocks.
Myriad Genetics (MYGN) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 4 hours and 32 minutes.
